AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
FAILURE IN IMMUNE REGULATION BEGETS IDDM IN NOD MICE
Authors: CAMERON MJ MEAGHER C DELOVITCH TL
Citation: Mj. Cameron et al., FAILURE IN IMMUNE REGULATION BEGETS IDDM IN NOD MICE, Diabetes/metabolism reviews, 14(2), 1998, pp. 177-185
MODULATION OF INTRAISLET CHEMOKINES BY CD-28 COSTIMULATION IN-VIVO
Authors: CAMERON MJ ARREAZA GA DELOVITCH TL
Citation: Mj. Cameron et al., MODULATION OF INTRAISLET CHEMOKINES BY CD-28 COSTIMULATION IN-VIVO, Diabetes, 47, 1998, pp. 774-774
TUMOR-INDUCED SUPPRESSION OF ANTITUMOR REACTIVITY AND DEPRESSION OF TCR-ZETA EXPRESSION IN TUMOR-DRAINING LYMPH-NODE LYMPHOCYTES - POSSIBLERELATIONSHIP TO THE TH2 PATHWAY
Authors: FU EJ ARCA MJ HAIN JM KRINOCK R RADO J CAMERON MJ CHANG AE SONDAK VK
Citation: Ej. Fu et al., TUMOR-INDUCED SUPPRESSION OF ANTITUMOR REACTIVITY AND DEPRESSION OF TCR-ZETA EXPRESSION IN TUMOR-DRAINING LYMPH-NODE LYMPHOCYTES - POSSIBLERELATIONSHIP TO THE TH2 PATHWAY, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 111-122
CONCURRENT INDUCTION OF CD4(-CELLS DURING TUMOR-GROWTH WITH ANTITUMORREACTIVITY IN ADOPTIVE IMMUNOTHERAPY() AND CD8(+) T)
Authors: ARCA MJ KRAUSS JC ARUGA A CAMERON MJ CHANG AE
Citation: Mj. Arca et al., CONCURRENT INDUCTION OF CD4(-CELLS DURING TUMOR-GROWTH WITH ANTITUMORREACTIVITY IN ADOPTIVE IMMUNOTHERAPY() AND CD8(+) T), Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 138-145
CYTOKINE-MEDIATED AND COSTIMULATION-MEDIATED THERAPY OF IDDM
Authors: CAMERON MJ ARREAZA GA DELOVITCH TL
Citation: Mj. Cameron et al., CYTOKINE-MEDIATED AND COSTIMULATION-MEDIATED THERAPY OF IDDM, Critical reviews in immunology, 17(5-6), 1997, pp. 537-544
DIFFERENT CYTOKINE PROFILES RELEASED BY CD4(-DRAINING LYMPH-NODE CELLS INVOLVED IN MEDIATING TUMOR-REGRESSION() AND CD8(+) TUMOR)
Authors: ARUGA A ARUGA E CAMERON MJ CHANG AE
Citation: A. Aruga et al., DIFFERENT CYTOKINE PROFILES RELEASED BY CD4(-DRAINING LYMPH-NODE CELLS INVOLVED IN MEDIATING TUMOR-REGRESSION() AND CD8(+) TUMOR), Journal of leukocyte biology, 61(4), 1997, pp. 507-516
ADOPTIVE IMMUNOTHERAPY WITH VACCINE-PRIMED LYMPH-NODE CELLS SECONDARILY ACTIVATED WITH ANTI-CD3 AND INTERLEUKIN-2
Authors: CHANG AE ARUGA A CAMERON MJ SONDAK VK NORMOLLE DP FOX BA SHU SY
Citation: Ae. Chang et al., ADOPTIVE IMMUNOTHERAPY WITH VACCINE-PRIMED LYMPH-NODE CELLS SECONDARILY ACTIVATED WITH ANTI-CD3 AND INTERLEUKIN-2, Journal of clinical oncology, 15(2), 1997, pp. 796-807
CD28 COSTIMULATION PREVENTS INSULIN-DEPENDENT DIABETES BY AN IL-4 DEPENDENT MECHANISM IN NOD MICE
Authors: ARREAZA GA CAMERON MJ CHAKRABARTI S DELOVITCH TL
Citation: Ga. Arreaza et al., CD28 COSTIMULATION PREVENTS INSULIN-DEPENDENT DIABETES BY AN IL-4 DEPENDENT MECHANISM IN NOD MICE, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1977-1977
IL-4 PREVENTS INSULITIS AND INSULIN-DEPENDENT DIABETES-MELLITUS IN NONOBESE DIABETIC MICE BY POTENTIATION OF REGULATORY T-HELPER-2 CELL-FUNCTION
Authors: CAMERON MJ ARREAZA GA ZUCKER P CHENSUE SW STRIETER RM CHAKRABARTI S DELOVITCH TL
Citation: Mj. Cameron et al., IL-4 PREVENTS INSULITIS AND INSULIN-DEPENDENT DIABETES-MELLITUS IN NONOBESE DIABETIC MICE BY POTENTIATION OF REGULATORY T-HELPER-2 CELL-FUNCTION, The Journal of immunology, 159(10), 1997, pp. 4686-4692
NEONATAL ACTIVATION OF CD28 SIGNALING OVERCOMES T-CELL ANERGY AND PREVENTS AUTOIMMUNE DIABETES BY AN IL-4-DEPENDENT MECHANISM
Authors: ARREAZA GA CAMERON MJ JARAMILLO A GILL BM HARDY D LAUPLAND KB RAPOPORT MJ ZUCKER P CHAKRABARTI S CHENSUE SW QIN HY SINGH B DELOVITCH TL
Citation: Ga. Arreaza et al., NEONATAL ACTIVATION OF CD28 SIGNALING OVERCOMES T-CELL ANERGY AND PREVENTS AUTOIMMUNE DIABETES BY AN IL-4-DEPENDENT MECHANISM, The Journal of clinical investigation, 100(9), 1997, pp. 2243-2253
INTERLEUKIN-4 - POTENTIAL IMMUNOREGULATORY AGENT IN THERAPY OF INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: ARREAZA GA CAMERON MJ DELOVITCH TL
Citation: Ga. Arreaza et al., INTERLEUKIN-4 - POTENTIAL IMMUNOREGULATORY AGENT IN THERAPY OF INSULIN-DEPENDENT DIABETES-MELLITUS, CLINICAL IMMUNOTHERAPEUTICS, 6(4), 1996, pp. 251-260
THERAPEUTIC EFFICACY OF T-CELLS DERIVED FROM LYMPH-NODES DRAINING A POORLY IMMUNOGENIC TUMOR TRANSDUCED TO SECRETE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: ARCA MJ KRAUSS JC ARUGA A CAMERON MJ SHU SY CHANG AE
Citation: Mj. Arca et al., THERAPEUTIC EFFICACY OF T-CELLS DERIVED FROM LYMPH-NODES DRAINING A POORLY IMMUNOGENIC TUMOR TRANSDUCED TO SECRETE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Cancer gene therapy, 3(1), 1996, pp. 39-47
COMPONENT ANALYSIS AND STIMULUS-CONTROL ASSESSMENT OF A BEHAVIOR DECELERATION TREATMENT PACKAGE
Authors: CAMERON MJ LUISELLI JK LITTLETON RF FERRELLI L
Citation: Mj. Cameron et al., COMPONENT ANALYSIS AND STIMULUS-CONTROL ASSESSMENT OF A BEHAVIOR DECELERATION TREATMENT PACKAGE, Research in developmental disabilities, 17(3), 1996, pp. 203-215
DIRECT TRANSFER OF A FOREIGN MHC GENE INTO HUMAN-MELANOMA ALTERS T-CELL RECEPTOR V-BETA USAGE BY TUMOR-INFILTRATING LYMPHOCYTES
Authors: DEBRUYNE LA CHANG AE CAMERON MJ YANG ZY GORDON D NABEL EG NABEL GJ BISHOP DK
Citation: La. Debruyne et al., DIRECT TRANSFER OF A FOREIGN MHC GENE INTO HUMAN-MELANOMA ALTERS T-CELL RECEPTOR V-BETA USAGE BY TUMOR-INFILTRATING LYMPHOCYTES, Cancer immunology and immunotherapy, 43(1), 1996, pp. 49-58
DIVERSE MANIFESTATIONS OF TUMORIGENICITY AND IMMUNOGENICITY DISPLAYEDBY THE POORLY IMMUNOGENIC B16-BL6 MELANOMA TRANSDUCED WITH CYTOKINE GENES
Authors: ARCA MJ KRAUSS JC STROME SE CAMERON MJ CHANG AE
Citation: Mj. Arca et al., DIVERSE MANIFESTATIONS OF TUMORIGENICITY AND IMMUNOGENICITY DISPLAYEDBY THE POORLY IMMUNOGENIC B16-BL6 MELANOMA TRANSDUCED WITH CYTOKINE GENES, Cancer immunology and immunotherapy, 42(4), 1996, pp. 237-245
IMMUNE-RESPONSE IN HUMAN-MELANOMA AFTER TRANSFER OF AN ALLOGENEIC CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX GENE WITH DNA-LIPOSOME COMPLEXES
Authors: NABEL GJ GORDON D BISHOP DK NICKOLOFF BJ YANG ZY ARUGA A CAMERON MJ NABEL EG CHANG AE
Citation: Gj. Nabel et al., IMMUNE-RESPONSE IN HUMAN-MELANOMA AFTER TRANSFER OF AN ALLOGENEIC CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX GENE WITH DNA-LIPOSOME COMPLEXES, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15388-15393
A PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA
Authors: CHANG AE CAMERON MJ SONDAK VK GEIGER JD VANDERWOUDE DL
Citation: Ae. Chang et al., A PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 253-262
GENERATION OF THERAPEUTIC T-LYMPHOCYTES AFTER IN-VIVO TUMOR TRANSFECTION WITH AN ALLOGENEIC CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX GENE
Authors: WAHL WL STROME SE NABEL GJ PLAUTZ GE CAMERON MJ SAN H FOX BA SHU SY CHANG AE
Citation: Wl. Wahl et al., GENERATION OF THERAPEUTIC T-LYMPHOCYTES AFTER IN-VIVO TUMOR TRANSFECTION WITH AN ALLOGENEIC CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX GENE, Journal of immunotherapy with emphasis on tumor immunology, 17(1), 1995, pp. 1-11
LYMPHOBLAST ENDOTHELIAL INTERACTIONS UNDER SHEAR-STRESS IN ADOPTIVE IMMUNOTHERAPY (AI)
Authors: STOOLMAN LM CRAIG RA CAMERON MJ CHANG AE BALLEW JR
Citation: Lm. Stoolman et al., LYMPHOBLAST ENDOTHELIAL INTERACTIONS UNDER SHEAR-STRESS IN ADOPTIVE IMMUNOTHERAPY (AI), The FASEB journal, 9(3), 1995, pp. 269-269
DIRECT GENE-TRANSFER OF HLA-B7 INTO HUMAN-MELANOMA ALTERS T-CELL RECEPTOR-V BETA-USAGE BY TUMOR-INFILTRATING LYMPHOCYTES
Authors: DEBRUYNE LA CHANG AE CAMERON MJ NABEL GJ BISHOP DK
Citation: La. Debruyne et al., DIRECT GENE-TRANSFER OF HLA-B7 INTO HUMAN-MELANOMA ALTERS T-CELL RECEPTOR-V BETA-USAGE BY TUMOR-INFILTRATING LYMPHOCYTES, The FASEB journal, 9(3), 1995, pp. 494-494
BEYOND CONSEQUENCES
Authors: CAMERON MJ KIMBALL JW
Citation: Mj. Cameron et Jw. Kimball, BEYOND CONSEQUENCES, MENTAL RETA, 33(4), 1995, pp. 268-270
EFFICIENT TRANSDUCTION OF EARLY-PASSAGE HUMAN-MELANOMA TO SECRETE IL-4
Authors: KRAUSS JC CAMERON MJ PARK AN FORSLUND K CHANG AE
Citation: Jc. Krauss et al., EFFICIENT TRANSDUCTION OF EARLY-PASSAGE HUMAN-MELANOMA TO SECRETE IL-4, Journal of immunological methods, 183(2), 1995, pp. 239-250
APPLICATION OF FLOW-CYTOMETRY TO DETERMINE THE CYTOTOXICITY OF URETHANE DIMETHACRYLATE IN HUMAN-CELLS (VOL 28, PG 153, 1994)
Authors: NASSIRI MR HANKS CT CAMERON MJ STRAWN SE CRAIG RG
Citation: Mr. Nassiri et al., APPLICATION OF FLOW-CYTOMETRY TO DETERMINE THE CYTOTOXICITY OF URETHANE DIMETHACRYLATE IN HUMAN-CELLS (VOL 28, PG 153, 1994), Journal of biomedical materials research, 29(3), 1995, pp. 417-417
BEHAVIORAL MEDICINE TREATMENT OF RUMINATIVE VOMITING AND ASSOCIATED WEIGHT-LOSS IN AN ADOLESCENT WITH AUTISM
Authors: LUISELLI JK MEDEIROS J JASINOWSKI C SMITH A CAMERON MJ
Citation: Jk. Luiselli et al., BEHAVIORAL MEDICINE TREATMENT OF RUMINATIVE VOMITING AND ASSOCIATED WEIGHT-LOSS IN AN ADOLESCENT WITH AUTISM, Journal of autism and developmental disorders, 24(5), 1994, pp. 619-629
APPLICATION OF FLOW-CYTOMETRY TO DETERMINE THE CYTOTOXICITY OF URETHANE DIMETHACRYLATE IN HUMAN-CELLS
Authors: NASSIRI MR HANKS CT CAMERON MJ STRAWN SE CRAIG RG
Citation: Mr. Nassiri et al., APPLICATION OF FLOW-CYTOMETRY TO DETERMINE THE CYTOTOXICITY OF URETHANE DIMETHACRYLATE IN HUMAN-CELLS, Journal of biomedical materials research, 28(2), 1994, pp. 153-158
Risultati: 1-25 | 26-27